| Target Price | $408.00 |
| Price | $341.89 |
| Potential | 19.34% |
| Number of Estimates | 39 |
| 39 Analysts have issued a price target Visa 2026 . The average Visa target price is $408.00. This is 19.34% higher than the current stock price. The highest price target is $446.25 30.52% , the lowest is $307.25 10.13% . | |
| A rating was issued by 45 analysts: 36 Analysts recommend Visa to buy, 9 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Visa stock has an average upside potential 2026 of 19.34% . Most analysts recommend the Visa stock at Purchase. |
41 Analysts have issued a sales forecast Visa 2025 . The average Visa sales estimate is $40.7b . This is 4.58% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $42.1b 8.19% , the lowest is $38.8b 0.22% .
This results in the following potential growth metrics:
| 2024 | $35.9b | 10.02% |
|---|---|---|
| 2025 | $40.7b | 13.22% |
| 2026 | $45.0b | 10.70% |
| 2027 | $49.6b | 10.04% |
| 2028 | $57.9b | 16.80% |
29 Analysts have issued an Visa EBITDA forecast 2025. The average Visa EBITDA estimate is $28.6b . This is 5.66% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $30.4b 12.41% , the lowest is $25.6b 5.46% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2024 | $25.1b | 9.71% |
|---|---|---|
| 2025 | $28.6b | 13.88% |
| 2026 | $31.8b | 11.37% |
| 2027 | $35.1b | 10.44% |
| 2028 | $39.9b | 13.48% |
| 2029 | $42.5b | 6.63% |
| 2024 | 69.84% | 0.28% |
|---|---|---|
| 2025 | 70.25% | 0.59% |
| 2026 | 70.67% | 0.60% |
| 2027 | 70.92% | 0.35% |
| 2028 | 68.91% | 2.83% |
40 Visa Analysts have issued a net profit forecast 2025. The average Visa net profit estimate is $22.5b . This is 12.29% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $23.4b 16.84% , the lowest is $21.4b 6.78% .
This results in the following potential growth metrics and future Net Margins:
| 2024 | $19.5b | 14.53% |
|---|---|---|
| 2025 | $22.5b | 15.78% |
| 2026 | $25.3b | 12.23% |
| 2027 | $28.5b | 12.81% |
| 2028 | $34.0b | 19.21% |
| 2029 | $36.9b | 8.57% |
| 2024 | 54.16% | 4.09% |
|---|---|---|
| 2025 | 55.38% | 2.26% |
| 2026 | 56.14% | 1.37% |
| 2027 | 57.55% | 2.51% |
| 2028 | 58.74% | 2.07% |
40 Analysts have issued a Visa forecast for earnings per share. The average Visa EPS is $11.67 . This is 13.85% higher than earnings per share in the financial year 2024. The highest EPS forecast is $12.14 18.44% , the lowest is $11.09 8.20% .
This results in the following potential growth metrics and future valuations:
| 2024 | $9.58 | 17.69% |
|---|---|---|
| 2025 | $11.67 | 21.82% |
| 2026 | $13.09 | 12.17% |
| 2027 | $14.77 | 12.83% |
| 2028 | $17.61 | 19.23% |
| 2029 | $19.11 | 8.52% |
| Current | 33.36 | 16.57% |
|---|---|---|
| 2025 | 29.31 | 12.13% |
| 2026 | 26.11 | 10.92% |
| 2027 | 23.15 | 11.34% |
| 2028 | 19.42 | 16.11% |
| 2029 | 17.89 | 7.88% |
Based on analysts' sales estimates for 2025, the Visa stock is valued at an EV/Sales of 16.34 and an P/S ratio of 16.19 .
This results in the following potential growth metrics and future valuations:
| Current | 17.09 | 11.26% |
|---|---|---|
| 2025 | 16.34 | 4.39% |
| 2026 | 14.76 | 9.67% |
| 2027 | 13.41 | 9.12% |
| 2028 | 11.48 | 14.39% |
| Current | 16.94 | 11.39% |
|---|---|---|
| 2025 | 16.19 | 4.38% |
| 2026 | 14.63 | 9.67% |
| 2027 | 13.29 | 9.12% |
| 2028 | 11.38 | 14.39% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Baird |
Outperform
➜
Outperform
|
Unchanged | Oct 06 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Jul 31 2025 |
| Macquarie |
Outperform
➜
Outperform
|
Unchanged | Jul 31 2025 |
| UBS |
Buy
➜
Buy
|
Unchanged | Jul 30 2025 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Jul 30 2025 |
| Deutsche Bank |
➜
Buy
|
Unchanged | Jul 17 2025 |
| Truist Securities |
Buy
➜
Buy
|
Unchanged | Jul 17 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Baird:
Outperform
➜
Outperform
|
Oct 06 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Jul 31 2025 |
|
Unchanged
Macquarie:
Outperform
➜
Outperform
|
Jul 31 2025 |
|
Unchanged
UBS:
Buy
➜
Buy
|
Jul 30 2025 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Jul 30 2025 |
|
Unchanged
Deutsche Bank:
➜
Buy
|
Jul 17 2025 |
|
Unchanged
Truist Securities:
Buy
➜
Buy
|
Jul 17 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


